We came across a bullish thesis on Boston Scientific Corporation on R. Dennis’s Substack by OppCost. In this article, we will ...

This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra ...

With a market cap of $138.8 billion, Boston Scientific Corporation (BSX)is a global medical device company that develops, ...

If you are wondering whether Boston Scientific's current share price still lines up with its long term potential, you are not ...

The deal for Penumbra will pay off in the long run. Hang on to the shares.

Boston Scientific (BSX) on Thursday announced a definitive agreement to acquire Penumbra (PEN) in a cash and stock ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Penumbra (PEN) climbs on strong Q4 results and acquisition agreement with Boston Scientific (BSX), deal valued at $14.5B.

Delving into the details, we found 47% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we ...

Boston Scientific Corporation (NYSE:BSX) is included in our list of the best stocks to buy right now. On January 12, 2026, ...

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value ...

Investing.com -- Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra (NYSE:PEN) in a transaction valued at roughly $14.5 billion, ...